Jenny L. Craven, PharmD, BCPS
Contact:
jlcraven@ucdavis.edu

Titles: Clinical Pharmacist, Emerging Therapy

Education: PharmD., Drake University, Des Moines 2010

Post-graduate Training:
PGY-1 Pharmacy Practice Residency, Iowa Methodist Medical Center, 2011

Research Interests:
Emerging therapies, drug information, internal medicine, pediatrics, managed care, lean principles

Practice Philosophy:
“The mind is not a vessel to be filled but a fire to be kindled.” – Plutarch

My practice philosophy is to always be inquisitive and to always be thinking about how even the best processes can be made better. To me, a great thing about being a pharmacist is becoming a mini expert on the pipeline drugs and discerning how they will fit in their rapidly expanding market baskets. But the best part of being a pharmacist is then connecting these innovative, efficacious, and often safer medications to the patients to see the entire trajectory of their lives potentially impacted for the better.

Rotations Precepted: PGY-1 Population Health; PGY-2 Population Health

Bio:
Dr. Craven earned a Doctorate of Pharmacy from Drake University in 2010 and completed a PGY-1 residency in pharmacy practice at Iowa Methodist Medical Center in 2011.

After residency, Dr. Craven worked as a pediatric pharmacist at the Baylor Scott & White McLane Children’s Medical Center. She then continued her career at Scripps Memorial Hospital La Jolla where she was a clinical pharmacist focused primarily on the emergency room, NICU, and internal medicine. Dr. Craven then went on to build an ambulatory internal medicine pharmacy service at the Naval Medical Center Camp Lejeune where she worked with patients in the clinic for anticoagulation, diabetes, heart failure, smoking cessation, and for inpatient pharmacy consults. From there, Dr. Craven pivoted to a managed care role as a drug information pharmacist at MedImpact, a pharmacy benefit manager. There she asserted place in therapy determinations for current and pipeline products (e.g., monographs, drug reviews), wrote and presented prior authorization criteria to a national P&T committee, fielded client and internal drug inquiries, and designed/maintained a drug information website.

In 2022, Dr. Craven blended her previous inpatient, outpatient, and managed care experience as the Emerging Therapies pharmacist at UC Davis Medical Center. In this role she monitors the pipeline for high cost and/or high impact medications and creates processes to streamline all stakeholder concerns (e.g., provider, clinic, contracts, acquisition, authorization, billing, administration, etc.) at UC Davis.